Epidemiologic evidence links high antioxidant status with low risk of
degenerative disease. Optimal intakes of antioxidants may not be achie
vable by diet alone; supplements may be taken, particularly in subgrou
ps of the population at high risk. It is thus necessary to ensure that
antioxidant supplements are safe and free from side effects. The toxi
city of vitamin E is low; no mutagenic, teratogenic, or carcinogenic e
ffects are known and in double-blind studies in which large amounts of
vitamin E were used in humans, no side effects occurred. High concent
rations are contraindicated in subjects with vitamin K-associated bloo
d coagulation disorders, and the toxicity in normal subjects ingesting
large amounts of vitamin E over long periods requires additional inve
stigation. Toxicity of beta-carotene also is low. Evidence from human
toxicity trials is not available but there is much circumstantial evid
ence that 15-50 mg/d is without side effects except for hypercarotenem
ia in some subjects at high intakes, The finding of more lung cancer i
n subjects who smoked and who were given 20 mg beta-carotene/d than in
those given a placebo could be influenced by the cancer being well ad
vanced before beta-carotene administration, Massive anecdotal evidence
exists that vitamin C (at greater than or equal to 1 g/d) is safe. Ex
haustive literature searches have failed to reveal a controlled study
of vitamin C toxicity in human subjects. Anxiety exists about oxalate
stone formation, uricosuria, vitamin B-12 destruction, mutagenicity, a
nd iron overload, but the consensus is that adverse effects do not occ
ur in healthy subjects ingesting large amounts of vitamin C.